Cargando…

Heterologous expression, immunochemical and computational analysis of recombinant human interferon alpha 2b

Interferon alpha 2b (IFNα-2b) is an important cytokine and used for antiviral and anticancer treatment. The low cost production of IFNα-2b with high biological activity is necessary to provide the interferon therapy to the hepatitis patients in Pakistan. In the present study, human interferon alpha...

Descripción completa

Detalles Bibliográficos
Autores principales: Gull, Iram, Samra, Zahoor Qadir, Aslam, Muhammad Shahbaz, Athar, Muhammad Amin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing AG 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3695685/
https://www.ncbi.nlm.nih.gov/pubmed/23875128
http://dx.doi.org/10.1186/2193-1801-2-264
_version_ 1782274999018586112
author Gull, Iram
Samra, Zahoor Qadir
Aslam, Muhammad Shahbaz
Athar, Muhammad Amin
author_facet Gull, Iram
Samra, Zahoor Qadir
Aslam, Muhammad Shahbaz
Athar, Muhammad Amin
author_sort Gull, Iram
collection PubMed
description Interferon alpha 2b (IFNα-2b) is an important cytokine and used for antiviral and anticancer treatment. The low cost production of IFNα-2b with high biological activity is necessary to provide the interferon therapy to the hepatitis patients in Pakistan. In the present study, human interferon alpha 2b (hIFNα-2b) gene from a healthy person was cloned and overexpressed in E. coli BL21(DE3). The molecular weight of the expressed hIFNα-2b is 19 kDa. The over expressed recombinant hIFNα-2b was checked by ELISA using antibodies raised against commercially available hIFNα-2b. The biocomputational analysis of recombinant hIFNα-2b gene showed the 99.9% nucleotide sequence and 100% deduced amino acid sequence homology with reported sequences of IFNα-2b. The predicted 3D-structure showed mainly five α-helices, one 3(10) helix and two disulfide bonds at Cys1-Cys98 and Cys129-Cys138. The amino acid sequence alignment indicated that the disulfide linkage position is conserved in all IFNα family members. On the basis of sequence homology among interferon alpha family, new potent variants of hIFNα-2b with enhance efficacy can be produced. Indigenous production of IFNα-2b from gene of local population will reduce the cost and increase tolerability of interferon therapy.
format Online
Article
Text
id pubmed-3695685
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Springer International Publishing AG
record_format MEDLINE/PubMed
spelling pubmed-36956852013-07-18 Heterologous expression, immunochemical and computational analysis of recombinant human interferon alpha 2b Gull, Iram Samra, Zahoor Qadir Aslam, Muhammad Shahbaz Athar, Muhammad Amin Springerplus Research Interferon alpha 2b (IFNα-2b) is an important cytokine and used for antiviral and anticancer treatment. The low cost production of IFNα-2b with high biological activity is necessary to provide the interferon therapy to the hepatitis patients in Pakistan. In the present study, human interferon alpha 2b (hIFNα-2b) gene from a healthy person was cloned and overexpressed in E. coli BL21(DE3). The molecular weight of the expressed hIFNα-2b is 19 kDa. The over expressed recombinant hIFNα-2b was checked by ELISA using antibodies raised against commercially available hIFNα-2b. The biocomputational analysis of recombinant hIFNα-2b gene showed the 99.9% nucleotide sequence and 100% deduced amino acid sequence homology with reported sequences of IFNα-2b. The predicted 3D-structure showed mainly five α-helices, one 3(10) helix and two disulfide bonds at Cys1-Cys98 and Cys129-Cys138. The amino acid sequence alignment indicated that the disulfide linkage position is conserved in all IFNα family members. On the basis of sequence homology among interferon alpha family, new potent variants of hIFNα-2b with enhance efficacy can be produced. Indigenous production of IFNα-2b from gene of local population will reduce the cost and increase tolerability of interferon therapy. Springer International Publishing AG 2013-06-15 /pmc/articles/PMC3695685/ /pubmed/23875128 http://dx.doi.org/10.1186/2193-1801-2-264 Text en © Gull et al.; licensee Springer. 2013 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Gull, Iram
Samra, Zahoor Qadir
Aslam, Muhammad Shahbaz
Athar, Muhammad Amin
Heterologous expression, immunochemical and computational analysis of recombinant human interferon alpha 2b
title Heterologous expression, immunochemical and computational analysis of recombinant human interferon alpha 2b
title_full Heterologous expression, immunochemical and computational analysis of recombinant human interferon alpha 2b
title_fullStr Heterologous expression, immunochemical and computational analysis of recombinant human interferon alpha 2b
title_full_unstemmed Heterologous expression, immunochemical and computational analysis of recombinant human interferon alpha 2b
title_short Heterologous expression, immunochemical and computational analysis of recombinant human interferon alpha 2b
title_sort heterologous expression, immunochemical and computational analysis of recombinant human interferon alpha 2b
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3695685/
https://www.ncbi.nlm.nih.gov/pubmed/23875128
http://dx.doi.org/10.1186/2193-1801-2-264
work_keys_str_mv AT gulliram heterologousexpressionimmunochemicalandcomputationalanalysisofrecombinanthumaninterferonalpha2b
AT samrazahoorqadir heterologousexpressionimmunochemicalandcomputationalanalysisofrecombinanthumaninterferonalpha2b
AT aslammuhammadshahbaz heterologousexpressionimmunochemicalandcomputationalanalysisofrecombinanthumaninterferonalpha2b
AT atharmuhammadamin heterologousexpressionimmunochemicalandcomputationalanalysisofrecombinanthumaninterferonalpha2b